These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10995961)

  • 1. Mixed allogeneic chimerism by combined use of nonlethal radiation and antilymphocyte serum in a rat small bowel transplantation model.
    Neto AB; DeFaria W; Berho M; Carreno M; Misiakos EP; Ruiz P; Inverardi L; Ricart F; Tsinari K; Miller J; Ricordi C; Tzakis AG
    Transplant Proc; 2000 Sep; 32(6):1311-2. PubMed ID: 10995961
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model.
    Bakonyi A; Berho M; Ruiz P; Misiakos EP; Carreno M; de Faria W; Sommariva A; Inverardi L; Miller J; Ricordi C; Tzakis AG
    Transplantation; 2001 Sep; 72(6):983-8. PubMed ID: 11579288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 6. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
    Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
    [No Abstract]   [Full Text] [Related]  

  • 7. Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation.
    Llull R; Murase N; Ye Q; Demetris AJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):1203-4. PubMed ID: 9123273
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.
    Kobayashi E; Kamada N; Enosawa S; Toyama N; Lord R; Stamatiou S; Delriviere L; Miyata M
    Transplant Proc; 1994 Jun; 26(3):1575-7. PubMed ID: 8030042
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants.
    Xia W; Brandeis JM; Sayegh M; Kirkman RL
    Transplant Proc; 1994 Jun; 26(3):1508-9. PubMed ID: 8030013
    [No Abstract]   [Full Text] [Related]  

  • 10. Can donor-specific transfusion via the portal vein under activated Kupffer cells enhance the beneficial effect of portal venous tolerance for rat small intestinal transplantation?
    Yamamoto S; Sato Y; Suda T; Kurosaki I; Okamoto H; Sakai Y; Hatakeyama K
    Transplant Proc; 2000 Nov; 32(7):2485. PubMed ID: 11120258
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and nonimmunosuppressed rats.
    de Bruin RW; Saat RE; Heineman E; Jeekel J; Marquet RL
    Transpl Int; 1993 Jan; 6(1):22-5. PubMed ID: 8452627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism.
    Orloff MS; Orloff SL; DeMara EM; Coppage ML; Leong N; Fallon MA
    Transplant Proc; 1994 Jun; 26(3):1585-6. PubMed ID: 8030048
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigating chronic rejection processes after experimental liver/small bowel transplantation.
    Meyer D; Gasser M; Heemann U; Otto Ch; Ulrichs K; Thiede A
    Transplant Proc; 2002 Sep; 34(6):2261-2. PubMed ID: 12270390
    [No Abstract]   [Full Text] [Related]  

  • 14. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
    Sun S; Greenstein SM; Schechner RS; Tellis VA
    Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune tolerance induced by administration of donor-specific antigen and cyclophosphamide in rat fetal small bowel transplantation.
    Nakao M; Shima Y; Ogita K; Taguchi T; Suita S
    Transplant Proc; 2000 Sep; 32(6):1252. PubMed ID: 10995934
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat.
    Nakao A; Yagi T; Matsukawa H; Endo A; Okada Y; Sun DS; Sadamori H; Inagaki M; Matsuno T; Tanaka N
    Transplant Proc; 2000 Nov; 32(7):2011-2. PubMed ID: 11120044
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of donor natural killer cells on lethal graft-versus-host disease following small bowel transplantation in the rat.
    Okamoto M; Arakawa K; Akioka K; Fujiwara I; Takeshita K; Oka T
    Transplant Proc; 1996 Oct; 28(5):2467-8. PubMed ID: 8907905
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of donor and recipient strains in isolated small bowel transplantation in rats.
    Tanabe M; Murase N; Demetris AJ; Hoffman RA; Nakamura K; Fujisaki S; Galvao FH; Todo S; Fung J; Starzl TE
    Transplant Proc; 1994 Dec; 26(6):3733-40. PubMed ID: 7527986
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
    Greenstein SM; Sun S; Schechner RS; Tellis VA
    Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.